Tissue Regenix Share Discussion Threads

[channel pirate] 11/10/2017 07:59

Wed, 11th Oct 2017 07:15

RNS Number : 2491T

Tissue Regenix Group PLC

11 October 2017




Hardman Research: Dual revenue stream growth

Dual revenue stream growth - TRX has a broad portfolio of regenerative medicine products developed from decellularised human and porcine soft tissues for the wound care, orthopaedics, and cardiac markets. Since the launch of DermaPure, focus has been on expanding in the US wound care and orthopaedic markets: in August 2017, TRX acquired CellRight Technologies, bringing in synergistic bone regeneration technology. FY'17 results will be the first to reflect the acquisition and will include 5 months of the enlarged entity. The 1H'17 results presented here are for stand-alone TRX, and show organic growth, both from the EU jv and from DermaPure, to a £1.38m total.

Please click here for the full report:

hxxp://hardmanandco.com/docs/default-source/company-docs/tissue-regenix--documents/11.10.17-dual-revenue-stream-growth.pdf

[multibagger] 29/9/2017 19:45

Hi Bamboo2...

In biotech and related spheres (other than major pharma), you get the best stock and company exposure with funds rather than specific companies and also limits downside risks.

Early stage companies in this field are effectively are a "all or none phenomenon" - bust more often than not. The challenge of commercialisation with all the regulatory hurdles and often having to be duplicated in different countries, pharmaco-economic analysis costs and the odd adverse event put paid to a number of prospective candidates.

Good luck all :)

[bamboo2] 29/9/2017 17:26

Cheers channel pirate and mb, This seems a classic case of great idea, but hard to monetise. Particularly in the UK.

Meniscus/tendon/cartilage off the shelf looks fantastic, but without a current CE mark, it is going nowhere. Xenografts have a great future, but my bet is that it will take one of the bigger pharmas in partnership or buyout to get these products to market.

[multibagger] 29/9/2017 12:35

multibagger11 Jul '14 - 08:15 - 947 of 2011 0 0 Edit

Hi Bamboo2.....as I have posted sometime ago the NHS is hardly the fastest adopter of new technology. The procurement process and bureaucratic hurdles test the patience of saints and I am not at all surprised by the information vacuum. Adoption of new tech is largely down to local factors.

Contrary to what many would expect, the NHS remains a patchwork of hospitals, CCGS with varying agendas, priorities and vision - there is no consistent approach to clinical issues (management and governance structures are slightly more consistent due to regulatory mechanisms).

What I would expect is a drip - drip of occasional contracts from the NHS - not an unified master contract. If anything better comes off, I would be delighted.

I have made good profits from TRX and taken them, so what is riding here is effectively free. My investment take on TRX is on the premise that they are / will be an attractive takeover candidate for a bigger pharma. It would be interesting to see how the US commercialisation takes off.

TRX are in the right field at the right time, but as I have mentioned I do not see their tech as being cutting edge. In a rapidly evolving field of regenerative medicine, they seem to holding onto "obsolete" low cost barrier tech....unless they are working on something very secretly !

Also after attending the AGM last year, I got the impression that communication is not the strength of the leadership team - further confirmed that my some recent emails which have been ignored.

I am not as excited as I once was and my take is probably also coloured by the fact that I have taken profits after re-assessing the overall situation.

Good luck all :)

[multibagger] 29/9/2017 12:28

Hi Bamboo2...good to see that you are out of this and I recall saying about 2-3 years ago that the TRX does not have enough cutting edge R&D and also commercialisation is going to be a huge challenge. So I am not surprised at all.

I also did not like the attitude of senior directors who did not have the courtesy to reply to emails. I attended one AGM and then made up my mind to get out.

Good luck to whoever chooses to stay in or is locked in -

Neil Woodford included !!

[channel pirate] 29/9/2017 10:35

Sorry to hear you have emptied your pot of TRX shares, but as said before, you have to go with your own gut feelings.

I to am disappointed at the company (not only this company) changing direction a bit, after all, we invest after doing our research and listening / looking at what news the company has furnished "Mr Joe public" with in order to attract our support (us buying shares).

I am hoping we have come to rest here somewhere near the bottom, so will hang in there for a time and hope for the best.

Good Luck bamboo2

[bamboo2] 29/9/2017 09:13

I am disappointed by the change to the US set up. It seems to me that the original plan has failed.

It has gone very quiet on the Meniscus/ACL news, which seems a shame.

I no longer hold any trx shares. Will wait for positive signs.

[alphapig] 28/9/2017 14:02

They've issued 0700 hrs rns' for last two interim results. Doesn't fill me with confidence that they're delayed this time.

[ali47fish] 28/9/2017 09:36

i have not seen any results rns today- does anyone know why?

[channel pirate] 08/9/2017 09:09

Fri, 8th Sep 2017 07:00

RNS Number : 2015Q

Tissue Regenix Group PLC

08 September 2017

Tissue Regenix Group plc


Notice of Interim Results and Capital Markets Day

Leeds, 8 September 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company, today gives notice that it will announce its interim results for the six months ending 31 June 2017, on Thursday 28 September 2017.

The Group will also host a Capital Markets Day in London on Thursday 12 October where it will provide an update on business activities and the integration of CellRight Technologies, with presentations from top level UK and US management.

[channel pirate] 30/8/2017 19:29

A few more shares being added to the pot ..............


30/08/2017 5:15pm

UK Regulatory (RNS & others)

Tissue Regenix (LSE:TRX)
Intraday Stock Chart

Today : Wednesday 30 August 2017
Click Here for more Tissue Regenix Charts.
TIDMTRX

RNS Number : 3527P

Tissue Regenix Group PLC

30 August 2017

Tissue Regenix Group Plc

Issue of equity and total voting rights

Leeds, 30 August 2017 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Company"), the regenerative medical devices company, announces that it has today issued and allotted 711,083 ordinary shares of 0.5p each in the Company, following an exercise of options which were granted under the Company's unapproved employee share option plan and 2016 DAB award.

The 711,083 new ordinary shares will rank pari passu with the existing ordinary shares and application has been made for these new ordinary shares to be admitted to trading on AIM. It is expected that Admission will occur at 8:00a.m. on Monday 4 September 2017.

Total Voting Rights

Following the issue of the 711,083 new ordinary shares, the Company will have a total of 1,161,779,838 ordinary shares of 0.5p each in issue. The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

[channel pirate] 25/8/2017 20:52

Well the company are good at manufacturing tissue to repair / heal wounds etc, so maybe they ought to manufacture a positive RNS that will repair the share price which has been severely wounded over the past few months !!

[rayrac] 16/8/2017 12:38

Well, Woodford is keen! Keeps doing us a favour?

[channel pirate] 15/8/2017 15:30

So a 400,000 SELL trade at 14.50p, and another SELL of 1,000,000 at 15.00p this afternoon, surely not a pi, but probably one of the "big boys" who took part in the recent placing at 10p now offloading some of their "OLD" shares (not placing shares) in order to get some dosh back as I mentioned might happen in a previous post !!

[loldemort] 14/8/2017 11:17

Yes, that's the feeling I'm getting: an expansion for new markets, rather than a coalescing retrenchment. All depends on how the management team takes it from here.

[rayrac] 14/8/2017 09:38

Im invested here because it feels like like a true takeover situation. We shall see?

[grahamburn] 11/8/2017 17:31

Interesting how both Woodford and Invesco have upped their stakes in the recent fundraising.

[rayrac] 11/8/2017 16:29

I think they split my trade into two 25's.

[bamboo2] 11/8/2017 16:25

Certainly looking a little more healthy this week. Quite a low volume breakout, so lets hope it sticks.

[rayrac] 11/8/2017 16:18

Been settled,just! Hope its not me driving the sp! 🤔😂

[rayrac] 11/8/2017 16:07

Quite difficult to buy it seems! I have an order in for a third more.

[rayrac] 11/8/2017 15:58

Well, I'm holding 100k shares at the moment and more buying by the II's!

The management dont seem to bad, just everyone watching and waiting. I think they are juicy meat for larger companies. But dont quote me!

[loldemort] 11/8/2017 15:57

If the Americans they've hired are any good, they'll try to take the company out of British hands. How they'll try to do it tho, is anyone's guess. Bid -- yay!. Driving down the price -- boo!

[andrewbaker] 11/8/2017 15:05

Adding to and following on from post 1934 in June, it's heartening to know that even a business that's not blessed with the best management, can become compelling when the product is really good and the share price way too low. What we really need is better figures, and better management; then this can really go. I'd buy more, but I'm already loaded to the gills, and can't destabilise my portfolio by doing so: so ... you guys drink your fill, and enjoy what should be, better late that never, a big rise northwards (and more northwards than before, too).

... Couldn't resist it: bought another 15,000 at 13.95p. I'm holding a heck of a lot more, so ok for this top-up, IMHO. lol. :)